{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:54:15Z","timestamp":1790247255563,"version":"4.1.0"},"reference-count":57,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI116497"],"award-info":[{"award-number":["U19AI116497"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI144297"],"award-info":[{"award-number":["U19AI144297"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Texas Medical Center Digestive Diseases Center (DDC) under the National Institute of Diabetes and Digestive and Kidney Diseases","award":["DK056338"],"award-info":[{"award-number":["DK056338"]}]},{"name":"Integrated Microscopy Core at Baylor College of Medicine and the Center for Advanced Microscopy and Image Informatics"},{"name":"NIH","award":["DK56338"],"award-info":[{"award-number":["DK56338"]}]},{"name":"NIH","award":["CA125123"],"award-info":[{"award-number":["CA125123"]}]},{"name":"NIH","award":["ES030285"],"award-info":[{"award-number":["ES030285"]}]},{"name":"NIH","award":["S10OD030414"],"award-info":[{"award-number":["S10OD030414"]}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"crossref","award":["RP150578"],"award-info":[{"award-number":["RP150578"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"crossref","award":["RP170719"],"award-info":[{"award-number":["RP170719"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Viruses"],"abstract":"<jats:p>SARS-CoV-2 variants have demonstrated distinct epidemiological patterns and clinical presentations throughout the COVID-19 pandemic. Understanding variant-specific differences at the respiratory epithelium is crucial for understanding their pathogenesis. Here, we utilized human nasal organoid air\u2013liquid interface (HNO-ALI) cell cultures to compare the viral replication kinetics, innate immune response, and epithelial damage of six different strains of SARS-CoV-2 (B.1.2, WA, Alpha, Beta, Delta, and Omicron). All variants replicated efficiently in HNO-ALIs, but with distinct replication kinetic patterns. The Delta variant exhibited delayed replication kinetics, achieving a steady state at 6 days post-infection compared to 3 days for other variants. Cytokine analysis revealed robust pro-inflammatory and chemoattractant responses (IL-6, IL-8, IP-10, CXCL9, and CXCL11) in WA1, Alpha, Beta, and Omicron infections, while Delta significantly dampened the innate immune response, with no significant induction of IL-6, IP-10, CXCL9, or CXCL11. Immunofluorescence and H&amp;E analysis showed that all variants caused significant ciliary damage, though WA1 and Delta demonstrated less destruction at early time points (3 days post-infection). Together, these data show that, in our HNO-ALI model, the Delta variant employs a distinct \u201cstealth\u201d strategy characterized by delayed replication kinetics and epithelial cell innate immune evasion when compared to other variants of SARS-CoV-2, potentially explaining a mechanism that the Delta variant can use for its enhanced transmissibility and virulence observed clinically. Our findings demonstrate that variant-specific differences at the respiratory epithelium could explain some of the distinct clinical presentations and highlight the utility of the HNO-ALI system for the rapid assessment of emerging variants.<\/jats:p>","DOI":"10.3390\/v17101343","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:33:41Z","timestamp":1759757621000},"page":"1343","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Strain-Specific Variability in Viral Kinetics, Cytokine Response, and Cellular Damage in Air\u2013Liquid Cultures of Human Nasal Organoids After Infection with SARS-CoV-2"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-5094","authenticated-orcid":false,"given":"Gina M.","family":"Aloisio","sequence":"first","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"},{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"McBride","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letisha","family":"Aideyan","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1202-198X","authenticated-orcid":false,"given":"Emily M.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9256-8071","authenticated-orcid":false,"given":"Ashley M.","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubama","family":"Rajan","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin G.","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"},{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Henke","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ferlic-Stark","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Kambal","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Advanced Technology Cores, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina A.","family":"Mosa","sequence":"additional","affiliation":[{"name":"Advanced Technology Cores, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6029-5478","authenticated-orcid":false,"given":"Fabio","family":"Stossi","sequence":"additional","affiliation":[{"name":"Advanced Technology Cores, Baylor College of Medicine, Houston, TX 77030, USA"},{"name":"Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Blutt","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Piedra","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"},{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanthi","family":"Avadhanula","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"ref_1","unstructured":"Mathieu, E., Ritchie, H., Rod\u00e9s-Guirao, L., Appel, C., Giattino, C., Hasell, J., Macdonald, B., Dattani, S., Beltekian, D., and Ortiz-Ospina, E. (2025, October 01). Coronavirus Pandemic (COVID-19). Available online: https:\/\/ourworldindata.org\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41579-023-01003-z","article-title":"SARS-CoV-2 biology and host interactions","volume":"22","author":"Steiner","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41564-024-01878-5","article-title":"Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic","volume":"10","author":"Furnon","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref_4","unstructured":"(2025, October 01). World Health Organization 2023 data.who.int WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/data.who.int\/dashboards\/covid19."},{"key":"ref_5","unstructured":"CDC (2025, October 01). CDC Museum COVID-19 Timeline, Available online: https:\/\/www.cdc.gov\/museum\/timeline\/covid19.html."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"eabg3055","DOI":"10.1126\/science.abg3055","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3349\/ymj.2021.62.11.961","article-title":"SARS-CoV-2 Variants of Concern","volume":"62","author":"Choi","year":"2021","journal-title":"Yonsei Med. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3201\/eid2909.230142","article-title":"COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020\u20132021","volume":"29","author":"Atherstone","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S1473-3099(21)00685-X","article-title":"Increased risk of hospitalisation and death with the delta variant in the USA","volume":"21","author":"Bast","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron Escapes the Majority of Existing SARS-CoV-2 Neutralizing Antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7150\/ijms.79116","article-title":"Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages","volume":"20","author":"Wang","year":"2023","journal-title":"Int. J. Med Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.virs.2022.07.014","article-title":"Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China","volume":"37","author":"Yang","year":"2022","journal-title":"Virol. Sin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41422-022-00638-6","article-title":"Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209","volume":"32","author":"Ju","year":"2022","journal-title":"Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rajan, A., Weaver, A.M., Aloisio, G.M., Jelinski, J., Johnson, H.L., Venable, S.F., McBride, T., Aideyan, L., Piedra, F.-A., and Ye, X. (2022). The Human Nose Organoid Respiratory Virus Model: An Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio, 13.","DOI":"10.1128\/mbio.03511-21"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chiu, M.C., Li, C., Liu, X., Song, W., Wan, Z., Yu, Y., Huang, J., Xiao, D., Chu, H., and Cai, J.-P. (2022). Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants. mBio, 13.","DOI":"10.1128\/mbio.01944-22"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tran, B.M., Grimley, S.L., McAuley, J.L., Hachani, A., Earnest, L., Wong, S.L., Caly, L., Druce, J., Purcell, D.F.J., and Jackson, D.C. (2022). Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020835"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","article-title":"Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron","volume":"603","author":"Shuai","year":"2022","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.stemcr.2024.02.011","article-title":"Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants","volume":"19","author":"Masui","year":"2024","journal-title":"Stem Cell Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2300376120","DOI":"10.1073\/pnas.2300376120","article-title":"Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants","volume":"120","author":"Li","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e0190421","DOI":"10.1128\/jvi.01904-21","article-title":"Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection","volume":"96","author":"Rajan","year":"2022","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"106305","DOI":"10.1016\/j.jinf.2024.106305","article-title":"Infant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection","volume":"89","author":"Aloisio","year":"2024","journal-title":"J. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/infdis\/jiab097","article-title":"Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader","volume":"223","author":"Avadhanula","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1177\/41.11.7691930","article-title":"Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections","volume":"41","author":"Shi","year":"1993","journal-title":"J. Histochem. Cytochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/ecn.2022.0477","article-title":"Th1 cytokine endotype discriminates and predicts severe complications in COVID-19","volume":"33","author":"Hasegawa","year":"2022","journal-title":"Eur. Cytokine Netw."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chen, H., Liu, W., Wang, Y., Liu, D., Zhao, L., and Yu, J. (2021). SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. EBioMedicine, 70.","DOI":"10.1016\/j.ebiom.2021.103500"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pum, A., Ennemoser, M., Adage, T., and Kungl, A.J. (2021). Cytokines and Chemokines in SARS-CoV-2 Infections\u2014Therapeutic Strategies Targeting Cytokine Storm. Biomolecules, 11.","DOI":"10.3390\/biom11010091"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/JLB.4COVR0920-552RR","article-title":"Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients","volume":"109","author":"Maxwell","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: A national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK","volume":"9","author":"Drake","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.stemcr.2023.01.011","article-title":"SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants","volume":"18","author":"Hysenaj","year":"2023","journal-title":"Stem Cell Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Tanneti, N.S., Patel, A.K., Tan, L.H., Marques, A.D., Perera, R.A.P.M., Sherrill-Mix, S., Kelly, B.J., Renner, D.M., Collman, R.G., and Rodino, K. (2024). Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating. mBio, 15.","DOI":"10.1128\/mbio.03129-23"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"114076","DOI":"10.1016\/j.celrep.2024.114076","article-title":"SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia","volume":"43","author":"Meganck","year":"2024","journal-title":"Cell Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jmv.26580","article-title":"IL-10 Served as an Indicator in Severe COVID-19 Patients","volume":"93","author":"Huang","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","unstructured":"Wang, Y., Liu, C., Miao, X., Kong, D., Zhao, Y., Gong, W., and Ding, X. (2020). Therapeutic targeting of interleukin-6 for the treatment of COVID-19. Eur. Cytokine Netw., 1."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Qin, Z., Xiang, K., Su, D.-F., Sun, Y., and Liu, X. (2021). Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.595342"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"155389","DOI":"10.1016\/j.cyto.2020.155389","article-title":"Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients","volume":"138","author":"Anderberg","year":"2021","journal-title":"Cytokine"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"D\u2019rozario, R., Raychaudhuri, D., Bandopadhyay, P., Sarif, J., Mehta, P., Liu, C.S.C., Sinha, B.P., Roy, J., Bhaduri, R., and Das, M. (2023). Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19. Viruses, 15.","DOI":"10.3390\/v15020549"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Korobova, Z.R., Arsentieva, N.A., Liubimova, N.E., Dedkov, V.G., Gladkikh, A.S., Sharova, A.A., Chernykh, E.I., Kashchenko, V.A., Ratnikov, V.A., and Gorelov, V.P. (2022). A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169058"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study","volume":"22","author":"Nyberg","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","volume":"602","author":"Saito","year":"2021","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e0125721","DOI":"10.1128\/JVI.01257-21","article-title":"The NF-\u03baB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication","volume":"95","author":"Uhl","year":"2021","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02983-5","article-title":"SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-\u03baB","volume":"5","author":"Neufeldt","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Saito, A., Horie, M., and Nagase, T. (2018). TGF-\u03b2 Signaling in Lung Health and Disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082460"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-24521-x","article-title":"SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance","volume":"12","author":"Robinot","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ahn, J.H., Kim, J.M., Hong, S.P., Choi, S.Y., Yang, M.J., Ju, Y.S., Kim, Y.T., Kim, H.M., Rahman, T., and Chung, M.K. (2021). Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J. Clin. Investig., 131.","DOI":"10.1172\/JCI148517"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2022.11.030","article-title":"SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming","volume":"186","author":"Wu","year":"2022","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Osan, J., Talukdar, S.N., Feldmann, F., DeMontigny, B.A., Jerome, K., Bailey, K.L., Feldmann, H., and Mehedi, M. (2022). Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.00459-22"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Huang","year":"2020","journal-title":"Nat. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1343\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:23:39Z","timestamp":1759897419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["v17101343"],"URL":"https:\/\/doi.org\/10.3390\/v17101343","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}